Related Experiment Video
Updated: Aug 19, 2026

CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum
Published on: September 18, 2018
Protection against malaria induced by chirally modified Plasmodium falciparum's MSP-1 42 pseudopeptides
José Manuel Lozano1, Fabiola Espejo, Ricardo Vera
1Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá D.C., Colombia. jm_lozano@fidic.org.co
Abstract:
The C-terminal portion of the Plasmodium falciparum blood stage MSP-1 antigen plays a key role in invasion of human erythrocytes. The MSP-1(1282-1301) non-polymorphic 1585 peptide, from the processed MSP-1(42) fragment, is poorly immunogenic and highly alpha-helical [Angew. Chem. Int. Ed. 40 (2001) 4654]. Assessing the alpha-carbon asymmetry and its implication in the host immune response is proposed in this work to overcome the 1585 peptide's immunological properties. Accordingly, the effect of incorporating single D-amino acids and psi-[CH(2)-NH] isoster bonds into the 1585 peptide was examined both at the immunogenic and 3D-structure levels. Therefore, specific binding to RBCs is promoted by site-directed chiral modifications on the native peptide as well as by simultaneously combining specific D-substitutions with psi-[CH(2)-NH] isoster bonds transforming this molecule into a high specific HLAbeta1*1101 allele binder. D-analog pseudopeptide immunized animals induced antibodies selectively recognizing a recombinant as well as native MSP-1(42) and MSP-1(33) fragments. Protection and low parasitemia levels were induced in Aotus monkeys immunized with the EVLYL(dK)PLAGVYRSLKKQLE analog. Peptide alpha-carbon chiral transformation is therefore an important target for structural modulation and, consequently, represents a novel approach towards designing multi-component subunit-based malarial vaccines.
Insights
Modifying a malaria parasite peptide with D-amino acids and isoster bonds enhanced its immunogenicity and structural properties. This novel approach shows promise for developing effective subunit-based malaria vaccines against Plasmodium falciparum.
Area of Science:
- Immunology
- Structural Biology
- Vaccine Development
Background:
- The C-terminal portion of Plasmodium falciparum merozoite surface protein 1 (MSP-1) is crucial for erythrocyte invasion.
- The MSP-1(1585) peptide, derived from MSP-1(42), exhibits poor immunogenicity and a stable alpha-helical structure.
- Overcoming the immunological limitations of MSP-1(1585) is essential for developing effective malaria vaccines.
Purpose of the Study:
- To assess the impact of alpha-carbon asymmetry on the host immune response.
- To enhance the immunogenicity and structural properties of the MSP-1(1585) peptide.
- To explore novel strategies for designing subunit-based malaria vaccines.
Main Methods:
- Incorporation of single D-amino acids and psi-[CH(2)-NH] isoster bonds into the MSP-1(1585) peptide.
- Analysis of immunogenicity and 3D-structure modifications.
- Evaluation of specific binding to red blood cells (RBCs) and HLA alleles.
- Immunization of animals with modified peptides and assessment of antibody responses and protection.
Main Results:
- Site-directed chiral modifications, including D-substitutions and isoster bonds, enhanced specific binding to RBCs.
- The modified peptide demonstrated high specificity for the HLA-DRB1*1101 allele.
- Antibodies generated against D-analog pseudopeptides recognized native and recombinant MSP-1(42) and MSP-1(33) fragments.
- Immunization with a specific D-analog analog induced protection and reduced parasitemia in Aotus monkeys.
Conclusions:
- Peptide alpha-carbon chiral transformation is a viable strategy for structural modulation.
- This approach offers a novel pathway for designing multi-component subunit-based malaria vaccines.
- The study highlights the potential of D-amino acid incorporation for improving vaccine candidate efficacy.
Related Concept Videos
Malaria
Symbiosis
Diversity of Protists II
Antiprotozoal Agents

